Bovine Mastitis Market, by Type (Clinical Mastitis and Sub-clinical Mastitis), by Product (Antibiotics, Vaccines, Pain Killers, and Others), by Route of Administration (Intra-mammary and Systemic), by Therapy (Lactating Period, Dry Period (Antibiotics, an

Bovine Mastitis Market, by Type (Clinical Mastitis and Sub-clinical Mastitis), by Product (Antibiotics, Vaccines, Pain Killers, and Others), by Route of Administration (Intra-mammary and Systemic), by Therapy (Lactating Period, Dry Period (Antibiotics, and Teat Sealants)), by End User (Veterinary Centers, Hospital, Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Bovine mastitis is characterized by a prolonged and inflammatory response of the udder tissue, as a result of either physical trauma or microorganism-caused illnesses. It is a life threatening mammary gland infection that is most prevalent in dairy cows globally. It's a condition known for causing damage on the dairy industry's profit margin. Mastitis is caused by a huge number of different microorganism species. Viruses, mycoplasmas, fungi, and bacteria are among them. Mastitis manifests itself as a red, hardened lump in the udder. The enlarged mammary gland is extremely hot, and even touching it causes pain and discomfort in animals. To avoid milking, animals will not touch or kick the udder. Blood clots, foul-smelling brown discharge, and milk clots are common in this condition.
Milk production comes to a halt or is seriously hampered as the animal's internal temperature rises. Lack of appetite, mobility issues due to a bloated udder, and soreness are some of the other symptoms of bovine mestitis. Sunken eyes, intestinal problems, and diarrhoea are all symptoms among dairy animals suffering from bovine mestitis. California Mastitis Test (CMT) can diagnose mastitis at an early stage (sub-clinical) before symptoms occur. It is a simple test that may be done on little amount of milk. Early identification aids in preventing the disease from progressing to clinical stages, which would result in significant losses for dairy farmers.
Market Dynamics
One of the primary factors driving the global bovine mastitis market expansion include increasing prevalence of bovine mastitis across the world. For instance, according to an article published by the US National Library of Medicine and National Institutes of Health in August 2020, at the quarter, cow, and farm level, the overall prevalence of clinical and subclinical mastitis was 51.6% (815/1,580), 74.4% (294/395), and 76.6% (118/154), respectively.
Key features of the study:
This report provides in-depth analysis of the global bovine mastitis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global bovine mastitis market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies.
Key companies covered as a part of this study include Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global bovine mastitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bovine mastitis market
Detailed Segmentation:
Global Bovine Mastitis Market, By Type:
Clinical Mastitis
Sub-clinical Mastitis
Global Bovine Mastitis Market, By Product:
Antibiotics
Vaccines
Pain Killers
Others
Global Bovine Mastitis Market, By Route of Administration:
Intra-mammary
Systemic
Global Bovine Mastitis Market, By Therapy:
Lactating Period
Dry Period
Antibiotics
Teat Sealants
Global Bovine Mastitis Market, By End User:
Veterinary Centers
Hospital
Clinics
Others
Global Bovine Mastitis Market, By Region:
North America
By Type
Clinical Mastitis
Sub-clinical Mastitis
By Product
Antibiotics
Vaccines
Pain Killers
Others
By Route of Administration
Intra-mammary
Systemic
By Therapy
Lactating Period
Dry Period
Antibiotics
Teat Sealants
By End User
Veterinary Centers
Hospital
Clinics
Others
By Country
U.S.
Canada
Latin America
By Type
Clinical Mastitis
Sub-clinical Mastitis
By Product
Antibiotics
Vaccines
Pain Killers
Others
By Route of Administration
Intra-mammary
Systemic
By Therapy
Lactating Period
Dry Period
Antibiotics
Teat Sealants
By End User
Veterinary Centers
Hospital
Clinics
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Type
Clinical Mastitis
Sub-clinical Mastitis
By Product
Antibiotics
Vaccines
Pain Killers
Others
By Route of Administration
Intra-mammary
Systemic
By Therapy
Lactating Period
Dry Period
Antibiotics
Teat Sealants
By End User
Veterinary Centers
Hospital
Clinics
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Type
Clinical Mastitis
Sub-clinical Mastitis
By Product
Antibiotics
Vaccines
Pain Killers
Others
By Route of Administration
Intra-mammary
Systemic
By Therapy
Lactating Period
Dry Period
Antibiotics
Teat Sealants
By End User
Veterinary Centers
Hospital
Clinics
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Type
Clinical Mastitis
Sub-clinical Mastitis
By Product
Antibiotics
Vaccines
Pain Killers
Others
By Route of Administration
Intra-mammary
Systemic
By Therapy
Lactating Period
Dry Period
Antibiotics
Teat Sealants
By End User
Veterinary Centers
Hospital
Clinics
Others
By Country
GCC
Israel
Rest of Middle East
Africa
By Type
Clinical Mastitis
Sub-clinical Mastitis
By Product
Antibiotics
Vaccines
Pain Killers
Others
By Route of Administration
Intra-mammary
Systemic
By Therapy
Lactating Period
Dry Period
Antibiotics
Teat Sealants
By End User
Veterinary Centers
Hospital
Clinics
Others
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Zoetis
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Bayer AG
Elanco
Ceva
West Way Health
Norbrook
DeLaval
ImmuCell Corporation
Advanced Animal Diagnostics
Nimrod Veterinary Products Ltd
“*” marked represents similar segmentation in other categories in the respective section.